Replies to post #123076 on Anavex Life Sciences Corp (AVXL)

[jakebanner]

If there were thousands of drugs targeting AD that failed the outlook for Anavex would be the same. Targeting amyloid plaques has failed and, logically, all other approaches that have failed have also not followed 2-73’s regimen. Failures do not affect Anavex’s chances of success, they only skew stats (percentages) and highlight the ineptitude of ineffective strategies.